ArticleOncotarget2016

Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

Laura Mediani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.